Showing results (171-180 of 354) with videos related to
Sort By:
Pageof 36
Journal of the National Cancer Institute|July 1, 1980
Extraction of a murine tumor-specific transplantation antigen with 1-butanol. I. Partial purification by isoelectric focusingS J LeGrue, B D Kahan, N R PellisClinical Pharmacology and Therapeutics|October 1, 1992
Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailabilityA Lindholm, M Welsh, C Alton, et al.Transplantation Proceedings|May 14, 2003
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipientsJ D Morrisett, G Abdel-Fattah, B D KahanExperimental Cell Biology|January 1, 1987
Protein synthesis in heterotopically transplanted rat heartsR W Currie, V K Sharma, S M Stepkowski, et al.Clinical Immunology and Immunopathology|September 1, 1989
In vivo use of monoclonal antibodies against murine T cell antigensR R Ghobrial, M Boublik, H J Winn, et al.Transplantation Proceedings|January 3, 2006
Use of FTY 720 and ICAM-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injuryP Troncoso, A M Ortiz, J Domínguez, et al.Cancer Research|December 1, 1986
Effects of concomitant and sinecomitant immunity on postsurgical metastasis in miceS Nomi, K Naito, B D Kahan, et al.Transplantation Proceedings|August 1, 1996
Oral cyclosporine preparations immediately following renal transplantationS M Katz, A Amante, L Schoenberg, et al.Transplantation|January 1, 1989
Isolation and in vitro characterization of a novel immunosuppressive cyclosporine metaboliteT Roesel, S J LeGrue, J Liehr, et al.Therapeutic Drug Monitoring|December 1, 1995
Potential applications of therapeutic drug monitoring of sirolimus immunosuppression in clinical renal transplantationB D Kahan, M G Murgia, J Slaton, et al.Pageof 36